Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/135359
Title: | Advancing the repurposing of ivermectin for malaria |
Author: | Chaccour, Carlos Rabinovich, Regina |
Keywords: | Malària Parasitologia mèdica Malaria Medical parasitology |
Issue Date: | 13-Apr-2019 |
Publisher: | Elsevier Ltd. |
Abstract: | There is ever-increasing anticipation for the potential of mass drug administration of endectocides (also known as systemic insecticides) to reduce malaria transmission, with ivermectin emerging as the most likely first-in-class endectocide.1 More than half of the 46 papers published on this subject in the past decade appeared in the past 2 years. 23 projects are registered in the MESA Track database, of which seven are active today; and, more importantly, trial mapping by the Malaria Ivermectin Roadmap2 shows that abundant new evidence on the topic will be available by 2020. |
Note: | Reproducció del document publicat a: http://dx.doi.org/10.1016/S0140-6736(18)32613-8 |
It is part of: | The Lancet, 2019, vol. 393, num. 10180, p. 1480-1481 |
URI: | http://hdl.handle.net/2445/135359 |
Related resource: | http://dx.doi.org/10.1016/S0140-6736(18)32613-8 |
ISSN: | 0140-6736 |
Appears in Collections: | Articles publicats en revistes (ISGlobal) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
ChaccourC_Lancet_2019.pdf | 103.56 kB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License